SCHEMBL858790

SCHEMBL858790

Cc1ncnc(N2CCOc3ccc(-c4cnc(N)c([N+](=O)[O-])c4)cc3C2)c1Cc1ccc(F)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.34
PIK3CA P42336 2/20 0.34
RPS6KB1 P23443 6/20 0.33
GPR142 Q7Z601 1/20 0.33
AURKA O14965 1/20 0.32
FLT1 P17948 1/20 0.32
GCK P35557 1/20 0.32
FLT4 P35916 1/20 0.32
MAP3K11 Q16584 1/20 0.32
STK17A Q9UEE5 1/20 0.32
TNIK Q9UKE5 1/20 0.32
ALK Q9UM73 2/20 0.32
GAA P10253 1/20 0.31
ALOX12 P18054 1/20 0.31
GFER P55789 1/20 0.31
KIT P10721 1/20 0.31
RIPK1 Q13546 1/20 0.31
MBOAT4 Q96T53 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL859239 0.89 RPS6KB1 (0.36) PRKDCPIK3CARPS6KB1GPR142AURKA
SCHEMBL856184 0.86 PIK3CA (0.38) PRKDCPIK3CARPS6KB1GPR142KIT
SCHEMBL3802990 0.85 PRKDC (0.44) PRKDCPIK3CARPS6KB1GPR142TNIK
SCHEMBL858829 0.85 PRKDC (0.38) PRKDCPIK3CARPS6KB1GPR142AURKA
SCHEMBL855967 0.81 PRKDC (0.33) PRKDCPIK3CARPS6KB1GPR142AURKA
SCHEMBL7860978 0.81 PRKDC (0.33) PRKDCPIK3CARPS6KB1GPR142AURKA
SCHEMBL856296 0.81 GRIA1 (0.34) PRKDCPIK3CARPS6KB1GPR142AURKA
SCHEMBL858299 0.81 RPS6KB1 (0.36) PRKDCPIK3CARPS6KB1GPR142AURKA
SCHEMBL858637 0.81 GPR142 (0.41) PRKDCPIK3CAGPR142RIPK1
SCHEMBL3755389 0.81 GRM5 (0.39) PRKDCPIK3CARPS6KB1MBOAT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 US disclosed
US-8648066-B2 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS, INC. (US) 2014-02-11 US disclosed
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 EP disclosed
WO-2012068096-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-24 WO disclosed
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2010-11-25 US disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA PRKDC 2737/4885PIK3CA 3/4885RPS6KB1 32/4885
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA PRKDC 2431/4885PIK3CA 3/4885RPS6KB1 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.